M.D. Sass Concentrated Value ETF
SASS
1 hedge funds and large institutions have $72.2M invested in M.D. Sass Concentrated Value ETF in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
7% more capital invested
Capital invested by funds: $67.4M → $72.2M (+$4.83M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5.5% less ownership
Funds ownership: 96.79% → 91.3% (-5.5%)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MDSL
M.D. Sass LLC
New York
|
-$710K |
| 2 |
GS
GTS Securities
Miami,
Florida
|
-$460K |
SASS Hedge Fund Activity: Q2 2026 in Review
1 of the 8,343 institutional investors tracked by Wall St. Rank reported a position in M.D. Sass Concentrated Value ETF (SASS) for Q2 2026, worth a combined $72.2M — up 7.2% from $67.4M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SASS and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was M.D. Sass LLC, cutting an estimated $710K.
- 1 institutional investor held M.D. Sass Concentrated Value ETF (SASS) as of Q2 2026, down from 2 in Q1 2026.
- Funds reported $72.2M of M.D. Sass Concentrated Value ETF stock for Q2 2026, up 7.2% quarter-over-quarter.
- 0 funds opened new M.D. Sass Concentrated Value ETF positions in Q2 2026 and 1 closed out, a net change of -1 holder.
- The largest M.D. Sass Concentrated Value ETF seller in Q2 2026 was M.D. Sass LLC, an estimated $710K sold.
Based on aggregated 13F filings for Q2 2026.